Log in to save to my catalogue

The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 asso...

The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 asso...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_02940533v1

The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma

About this item

Full title

The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma

Publisher

New York: Springer US

Journal title

Journal of neuro-oncology, 2017-10, Vol.135 (1), p.47-56

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Neurofibromatosis type 2 (NF2), a neurogenetic condition manifest by peripheral nerve sheath tumors (PNST) throughout the neuroaxis for which there are no approved therapies. In vitro and in vivo studies presented here examine agents targeting signaling pathways, angiogenesis, and DNA repair mechanisms. In vitro dose response assays demonstrated po...

Alternative Titles

Full title

The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_inserm_02940533v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_02940533v1

Other Identifiers

ISSN

0167-594X

E-ISSN

1573-7373

DOI

10.1007/s11060-017-2567-9

How to access this item